The Latin America, Middle East and Africa Implantable Cardiac Monitors Market would witness market growth of 8.5% CAGR during the forecast period (2018 – 2024).
The implantable cardiac monitor, which is also referred to as implantable loop recorder, is a tiny insertable device used in continuously monitoring hearth rhythms. The device is mostly placed in the left parasternal area of the chest. The device is also placed in some other parts of body, to minimize psychological impact of surgical scar in anterior chest region, without impairing the performance of the device. Technological advancements in cardiac monitoring devices in area of medical cardiology, improved diagnostics, ease of use, and increased adoption in both hospitals & homecare are key growth factors, which are driving the market growth. Additionally, rising awareness among users about devices and treatment options for cardiac disorders is expected to create lucrative opportunities for the market in the near future.
Based on Indication, the report is segmented into Cardiac Arrhythmias, Atrial Fibrillation and Epilepsy & Unexplained falls. Based on End User, the market is segmented into Hospitals, Ambulatory Surgery centers (ASCs) and Cardiac Center & Clinics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abiomed, Inc., Abbott Laboratories, Boston Scientific Corporation, Reliant Heart, Inc., Astellas Pharma Inc., Biotronik SE & Co. KG, Agilent Technologies, Inc., Berlin Heart GmbH ,Schiller AG, Jarvik Heart, Inc.
Scope of the Study
Market Segmentation:
By Indication
By End User
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
